Home›Stock Screener›Sai Life Sciences›Quarterly Results

Sai Life Sciences Quarterly Results for Trading Insights

Latest Quarter Net Profit
₹104 Cr
QMar 2026
Quarterly Results

In Mar 2026, Sai Life Sciences (SAILIFE) reported revenue ₹618 Cr and net profit ₹104 Cr — revenue +4.9% YoY. Also explore SAILIFE share price history to track price trends across different timeframes.

SAILIFE Quarterly Results — Revenue, Profit & EPS Highlights

Sai Life Sciences latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. For annual financials, live price and key ratios, visit SAILIFE share price screener.

  • Revenue of ₹618 Cr in Mar 2026 (+11.8% vs Sept 2025, +4.9% vs Mar 2025)
  • Net Profit of ₹104 Cr in Mar 2026 (+23.8% vs Sept 2025, +18.2% vs Mar 2025)
  • EBITDA of ₹192 Cr in Mar 2026 (+19.3% vs Sept 2025)
  • Operating Margin of 29.0% in Mar 2026 (+2.0pp vs Sept 2025)
  • Earnings Per Share of ₹4.93 in Mar 2026 (+22.9% vs Sept 2025)

Sai Life Sciences Quarterly Results — Revenue, EBITDA, Net Profit & EPS

SAILIFE quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Mar 2026 Sept 2025 Mar 2025 Jun 2025 Dec 2025 QoQ YoY
Revenue (₹ Cr) 618 553 589 506 565 11.8% 4.9%
Net Profit (₹ Cr) 104 84 88 61 100 - -
EBITDA (₹ Cr) 192 161 167 131 188 - -
EPS (₹) 4.93 4.01 4.24 2.90 4.77 - -
Operating Margin (%) 29.0% 27.0% 27.0% 24.0% 32.0% - -

SAILIFE Share Price Trend — 1-Year Movement Across Quarterly Results

Sai Life Sciences 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Compare with SAILIFE fair value to assess whether the stock is under or overvalued.

Profitability Ratios

Profit Margin 16.8%
EBITDA Margin 31.1%
Operating Margin 29.0%
ROE (Annual) 16.7%

Balance Sheet Highlights

Total Assets ₹3,626 Cr
Total Equity ₹2,484 Cr
Current Assets ₹1,411 Cr
Current Liabilities ₹309 Cr

Cash Flow Analysis

Operating Cash Flow ₹314 Cr
Investing Cash Flow ₹-536 Cr
Financing Cash Flow ₹301 Cr
Net Cash Flow ₹79 Cr

Current Market Data

Current Price ₹1131.20
Exchange NSE
Last Updated May 27, 2026

Revenue Trend (₹ Cr)

Jun 2025 506
Mar 2025 589
Sept 2025 553
Mar 2026 618

Net Profit Trend (₹ Cr)

Jun 2025 61
Mar 2025 88
Sept 2025 84
Mar 2026 104

Operating Margin Trend (%)

Jun 2025 24.0%
Mar 2025 27.0%
Sept 2025 27.0%
Mar 2026 29.0%

SAILIFE vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Sai Life Sciences latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Mar 2026 		₹442,581.33 Cr 1844.3 15,018 2,710 +1.0% +11.8% 18.0% 163.2
Divis Laboratories
Mar 2026 		₹179,363.85 Cr 6797.5 2,986 751 +4.4% +11.8% 25.2% 240.1
Torrent Pharmaceuti…
Mar 2026 		₹153,579.77 Cr 4537.8 4,111 364 +27.7% +42.2% 8.9% 394.2
Cipla
Mar 2026 		₹114,559.46 Cr 1418.2 6,612 543 -14.3% -4.0% 8.2% 206.4
Dr Reddys Laborator…
Mar 2026 		₹110,089.41 Cr 1319.0 7,996 221 -12.5% -11.5% 2.8% 497.7
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores